Cancer, Colorectal
31
4
9
12
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 31 trials
100.0%
+13.5% vs benchmark
10%
3 trials in Phase 3/4
0%
0 of 12 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 12 completed trials
Clinical Trials (31)
Family History App in Personalized Medicine
IMProving Adherence to Colonoscopy Through Teams and Technology
Postoperative Exercise Training and Colorectal Cancer Liver Metastasis
Onco-primary Care Networking to Support TEAM-based Care
Plant-based Diets and Risk of Cancer in the Adventist Health Study-2
Blood Screening for Adult Colorectal Cancer
Building Connections
Impact of a Patient Decision Aid Intervention
French Colorectal ESD Cohort in Experts Centers
Pharmaceutical Care for Patients Using Capecitabine
Interventions to Decrease Financial Toxicity
ImmigrantScreen Telephone Reminder Trial in Colorectal Cancer Screening
Genomic Testing and Resulting Medical Decisions
Early Detection of Five Common Cancers Using the ctDNA Analysing Test
A Study of Bi-Ligand-Drug Conjugate CBP-1019 in Patients With Advanced Solid Tumors
Exercise Effect on Chemotherapy-Induced Neuropathic Pain
ctDNA Methylation Application in Postoperative Relapse and Adjuvant Chemotherapy Efficacy Evaluation
Propofol and Sevoflurane Anesthesia in Colorectal Cancer Surgery: Incidence of Acute Kidney Injury
Digital Home-Based Prehabilitation Before Surgery
TWICE-IRI: Optimization of Second-line Therapy With Aflibercept, Irinotecan (Day 1 or Day 1,3), 5-Fluorouracile and Folinic Acid in Patients With Metastatic Colorectal Cancer. A Randomized Phase III Study.